Go to content
Feb 4th 2012
Suomeksi
Text size
Home
Orion
Products and services
Research and development
News and media
Investors
Sustainability
Careers
Home
/
Sitemap
Print
Sitemap
Orion
Orion in brief
Orion as a company
Orion Group operational structure
Best selling products
Business environment
Business Divisions
Proprietary Products
Specialty Products
Animal Health
Fermion
APIs
About Fermion
CRAMS
Contacts
Orion Diagnostica
Line functions
Supply Chain
Sales and Marketing
Research and Development
Operational model
Quality – the cornerstone
Orion's Quality Policy
Safety above all
Strict criteria for raw materials
Customers
Partnering / Licensing
Orion's partner management organisation
Partnering opportunities with Orion
Why partner with Orion?
Our partnership references
Strategy
Competitive product portfolio
Strengthening the market position in Europe
Flexible and efficient operations
Corporate Governance
Group level
Business Divisions and line functions
Administration of legal entities
General Meeting of Shareholders
Board of Directors
Board members
Nomination Committee members
Board Committees
Authorisations of the Board
President and CEO
Other executives
Remuneration statement
Risks and internal control
Strategic risks
Operational risks
Financial risks
Insider Administration
Audit
Articles of Association
General Meetings of Shareholders
AGM 31 March 2011
AGM 24 March 2010
AGM 23 March 2009
AGM 25 March 2008
AGM 2 April 2007
History
Phases in 1940-1950's
Phases in 1960-1970's
Phases in 1980-1990's
Structural developments
Demerger on 30 June 2006
Phases of the diagnostics business
Values
Orion Events Calendar
Products and services
Human prescription medicines
Orion's portfolio of prescription medicines
Proprietary products portfolio
Products by therapeutic areas
CNS products
Stalevo® and Comtess®/Comtan®
Parkinson's Disease
Urological products
Veterinary products
Aptus well-being range for pets
Active Pharmaceutical Ingredients
Fermion expands API plant in Oulu
Diagnostic tests
Hygiene tests
Awarded for innovation, Orion Clean Card® PRO
Contract Manufacturing
Manufacturing and Packaging
Cytostatics
Hormones
Liquids
Semi-Solid Forms
Small Volume Parenterals
Solid Oral Dosages
Supporting services
Analytical and Release Services
Artwork Services
Customer Service
Logistics
R & D Support
Contacts
Useful sources of information on pharmaceuticals and healthcare
Research and development
Proprietary Product Development
Non-clinical Research
Early development
Clinical Studies
Clinical Phase I
Clinical Phase II
Late development
Clinical Phase III
Biostatistics in Drug Development
Product Development
Drug registration and marketing authorisation
Drug Safety
Generic Development
Therapy areas of research
Central Nervous System medicines
Oncology and Critical Care
Inhaled medicinal products - the Easyhaler® platform
Generics
Animal Health
Achievements
R&D People
Contact information
R&D collaboration partnerships
R&D collaboration with Selvita
R&D collaboration with DelSiTech
R&D collaboration with Endo Pharmaceuticals
Orion in the PREDECT initiative
Innovative Medicines Initiative - IMI
R&D Vocabulary
The Best R&D in the World
News and media
Subscribe for publications
Stock exchange releases
Stock exchange announcements
Press releases
Annual Reports
Financial Reviews
2010
2009
2008
2007
2006
Presentations
Magazines
Material Bank
Media contacts
Investors
Orion as an investment case
Printable Fact Sheet
CEO's reviews
Operational enviroment
Market reviews
Financial objectives
Strategy
Business divisions
Top 10 pharmaceuticals
Patents
R&D in brief
R&D pipeline
Proprietary drugs
Outlook
Basis for outlook
Dividends
Consensus estimates
Analysts
Corporate Governance
Risk management
Calendar
Financials
Financial reporting
Financial objectives
Outlook
Credit programmes
Annual Reports
Interim Reports
Listing Particulars
Accounting policies
Calculation of key figures
Shares
Basic share information
Share capital
Share-related key figures
Treasury shares
Sharemonitor
Share price lookup
Total Return Calculator
Dividends
Shareholder base
Major shareholders by shares
Major shareholders by votes
Ownership structure
Type of shareholder in graphs
Flagging notifications
Insider register
Shareholder register
Investor contacts
Changes in contact details
Silent period
Messages to shareholders
Sustainability
Orion's approach to Corporate Responsibility
Orion Group Sustainability Report 2010
Foreword to Report 2010
GRI Content Index
Part I: Profile disclosure
Vision and strategy
Statement from senior management
Description of risks
Organisational profile
Report parameters
Governance, commitments and engagement
Stakeholder engagement
Economic Responsibility
Management approach of Economic Responsibility
Indicators of economic performance
EC Economic value added
EC3 Coverage of pension obligations
EC4 Financial assistance from government
EC Donations
Environmental Responsibility
Management approach of Environmental Responsibility
Responsible Care and Energy Efficiency
REACH and CLP
Indicators of environmental performance
EN1-2 Materials use
EN3-EN4 Direct and Indirect energy consumption
EN5 and EN7 Energy conservation
EN8 Water withdrawal and consumption
EN11 Land of high biodiversity value
EN16 Direct and indirect CO2 emissions
EN20 Emissions to air
EN21 Water discharges by way of treatment
EN22 Waste and EN24 Hazardous waste
EN Production volumes
EN26 Mitigation of environmental impacts
EN28 Environmental breaches
EN29 Environmental impacts of transportation
EN30 Environmental expenditures
Social Responsibility
LA – Labour Practices and Decent Work
Management approach of Labour Practices
Indicators of Labour
LA1 Total workforce
LA2 Employee turnover
LA3 Benefits to full-time employees
LA4-5 Collective agreements
LA6 HSE representation
LA7 Absenteeism
LA9 Health and safety topics covered
LA10-11 Training and education
LA12 Performance reviews
LA13 Gender and age structure
LA14 Wage equality
LA Job satisfaction
HR - Human Rights
Management approach of Human Rights
Indicators of Human Rights performance
Human Rights indicators HR4-HR9
SO - Society
Management approach of Society performance
Indicators of Society performance
Society indicators SO4-SO8
PR – Product Responsibility
Management approach of Product Responsibility
Indicators of Product Responsibility
PR1 Safety over life-cycle
PR2 Breaches of product regulations
PR Product traceability
PR Product recalls and defects
PR Inspections of operations
PR3-4 Obligatory product information
PR5 Customer Satisfaction
PR6-7 Marketing communictions compliance
PR8-9 Breaches in marketing
Orion Group Sustainability Report 2009
Introduction: Orion and Corporate Responsibility
Description of operations
Statement from senior management
Organisational profile
Report parameters
GRI Content Index
Governance, commitments and engagement
Commitments to initiatives
Stakeholder engagement
Economic Responsibility
Management approach of Economic Responsibility
Indicators of economic performance
EC Economic value added
EC3 Coverage of pension obligations
EC4 Financial assistance from government
EC Donations
Environmental Responsibility
Management approach of Environmental Responsibility
Responsible Care
REACH and CLP
Indicators of environmental performance
EN1-2 Materials use
EN3-EN4 Direct and Indirect energy consumption
EN5 and EN7 Energy conservation
EN8 Water witdrawal and consumption
EN21 Water discharges by way of treatment
EN11 Land of high biodiversity value
EN16 Direct and indirect CO2 emissions
EN20 Emissions to air
EN22 Waste
EN Production volumes
EN26 Mitigation of environmental impacts
EN28 Environmental breaches
EN29 Environmental impacts of transportation
EN30 Environmental expenditures
Social Responsibility
LA – Labour Practices and Decent Work
Management approach of Labour Practices
Indicators of Labour
LA1 Total workforce
LA2 Employee turnover
LA4-5 Collective agreements
LA7 Injuries
LA9-12 Training and development
LA13 Gender and age structure
LA14 Wage equality. Work satisfaction
HR - Human Rights
Management approach of Human Rights
Indicators of Human Rights performance
Human Rights indicators HR4-HR9
SO - Society
Management approach of Society performance
Indicators of Society performance
Society indicators SO4-SO8
PR – Product Responsibility
Management approach of Product Responsibility
Indicators of Product Responsibility
PR1 Safety over life-cycle
PR2 Breaches of product regulations
PR Product traceability
PR Product recalls and defects
PR Inspections of operations
PR3-4 Obligatory product information
PR5 Customer Satisfaction
PR6-7 Marketing communictions compliance
PR8-9 Breaches in marketing
Code of conduct
Codes for employees
Non-compliance
Areas covered by the Code
Personal obligations
Compliance with laws and regulations
Conflicts of interest
Bribery, hospitality and gifts
Charity, donations and support
Insider affairs
Treatment of company assets
Competition and business operations
Respect and appreciation
Patient safety
R&D ethics
Orion's Human Resources Policy
Environmental reports 2006, 2007 and 2008
Orion collaboration with Plan
Collaboration with patient organisations
Orion supports the Pink Ribbon campaign
Orion's collaboration with patient organizations in 2011
Orion's collaboration with patient organizations in 2010
Orion's collaboration with patient organizations in 2009
Orion's collaboration with patient organizations in 2008
Leverage from partnerships
Recognitions for achievements
Orion recognised for Excellence
Careers
Vacancies
Open vacancies
Open application
For students
Orion as a workplace
Key figures on Orion employees
Growth and development
Healthy and happy personnel
Builders of well-being
Orion Corporation, Orionintie 1A, 02200 Espoo, PO Box 65, FI-02101 Espoo, Finland
Phone +358 104261 © Copyright Orion Corporation. Company code, VAT 19992126,
Contacts
About this website
Disclaimer
Sitemap
Feedback form
